Advanced Search

column
Research progress of Polo-like kinase 1 inhibitors targeting Polo-box domain
YAO Aihong, CHANG Yujie, JIANG Cheng, SUN Haiying
2016, 47(1): 1-8. DOI: 10.11665/j.issn.1000-5048.20160101
Abstract PDF
PD-1/PD-Ls signaling pathway and the application of anti-PD-1/PD-Ls antibodies in cancer therapy
PAN Jiajia, JIA Xiaoqing, HUANG Gang, ZHANG Yubin
2016, 47(1): 9-18. DOI: 10.11665/j.issn.1000-5048.20160102
Abstract PDF
Advances in enrichment strategies for phosphoproteomics and its application in the research of disease
WU Weixin, YAN Jia, TAN Xiying, LI Bo, SU Mengxiang, YAN Fang, DI Bin
2016, 47(1): 19-29. DOI: 10.11665/j.issn.1000-5048.20160103
Abstract PDF
Synthesis and in vitro biological activity of 3-phenyl-3-pyrrolylpentane derivatives
XU Meng, GE Zhixin, HAO Meixi, ZHANG Can
2016, 47(1): 30-37. DOI: 10.11665/j.issn.1000-5048.20160104
Abstract PDF
Discovery of novel EphB4 inhibitors based on pharmacophore modeling and virtual screening techniques
SHAO Xin, YI Qianying, YANG Chunlei
2016, 47(1): 38-47. DOI: 10.11665/j.issn.1000-5048.20160105
Abstract PDF
Synthesis and antitumor activity of isosteviol derivatives
LIU Yan, WANG Tingting, CHEN Li
2016, 47(1): 48-53. DOI: 10.11665/j.issn.1000-5048.20160106
Abstract PDF
Determination of catechin, epicatechin, gallic acid and procyanidin B2 in procyanidins by RP-HPLC
ZHANG Lu, PAN Peipei, CHEN Saizhen
2016, 47(1): 54-57. DOI: 10.11665/j.issn.1000-5048.20160107
Abstract PDF
Identification of related substances in ambrisentan by LC-MS/MS
CHEN Leilin, SONG Min, ZHANG Ge, WANG Lei, HANG Taijun
2016, 47(1): 58-65. DOI: 10.11665/j.issn.1000-5048.20160108
Abstract PDF
Study of interaction between bovine serum albumin and nefopam enantiomers with affinity capillary monolith
ZENG Yu, JI Yibing
2016, 47(1): 66-72. DOI: 10.11665/j.issn.1000-5048.20160109
Abstract PDF
Pharmacokinetics of dimemorfan phosphate following single- and multiple-dose oral administration in healthy Chinese volunteers
YU Xiaxia, FU Jinfeng, ZHAO Hui, TIAN Yuan, ZHANG Zunjian
2016, 47(1): 73-78. DOI: 10.11665/j.issn.1000-5048.20160110
Abstract PDF
Shenmai injection inhibits inflammatory response in lipopolysaccharides-induced septic mice
CHAI Yingying, CAO Lijuan, ZHANG Haowen, CHEN Hanyu, WANG Guangji, HAO Haiping
2016, 47(1): 79-83. DOI: 10.11665/j.issn.1000-5048.20160111
Abstract PDF
Effects and mechanism of peroxiredoxin-6 on ultraviolet-induced corneal injury in rats
LYU Jiahui, JIANG Minmin, SHI Hui, LI Jianyuan, DU Zhenning
2016, 47(1): 84-89. DOI: 10.11665/j.issn.1000-5048.20160112
Abstract PDF
Cisplatin inhibits survival of human esophageal squamous carcinoma cells via p53 activation
GU Chunping, Que Fuchang, LI Yilei, LIU Shuwen, YU Le
2016, 47(1): 90-94. DOI: 10.11665/j.issn.1000-5048.20160113
Abstract PDF
In vitro study on the regulation of Shengmai San on dysbacteriosis of intestinal flora
HUA Haiying, LI Xueqing, LIU Jihua
2016, 47(1): 95-100. DOI: 10.11665/j.issn.1000-5048.20160114
Abstract PDF
Combination of scFv-AFP with doxorubicin inhibits cell proliferation in hepatocellular carcinoma cell Huh7
SHEN Yanli, JI Xiaonan, GAO Xiangdong
2016, 47(1): 101-105. DOI: 10.11665/j.issn.1000-5048.20160115
Abstract PDF
Condition of human Th17 cell differentiation induced in vitro
WANG Chen, GUO Wei, WANG Xin, YU Dongmei, WANG Yuheng, YAO Wenbing
2016, 47(1): 106-111. DOI: 10.11665/j.issn.1000-5048.20160116
Abstract PDF
Research progress of 1, 2-dilinoleyloxy-3-dimethylaminopropane-based cationic lipid nanoparticle
HU Yue, CHEN Zhou, LUO Xiaoxing, XUE Xiaoyan
2016, 47(1): 112-117. DOI: 10.11665/j.issn.1000-5048.20160117
Abstract PDF
Advances in lipid-lowering effect of PPARα agonists
HU Yue, XU Jun, LIU Yanhua, WANG Zengtao, HUANG Liming, FANG Jialong, WANG Chen
2016, 47(1): 118-124. DOI: 10.11665/j.issn.1000-5048.20160118
Abstract PDF

Total visits：